AMANTA HEALTHCARE LIMITED (AMANTA) financials

AMANTA HEALTHCARE LIMITED (AMANTA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]

Market Cap: ₹712Cr.
Current Price: ₹183
Stock P/E: 46.4
ROE: 10.3%
ROCE: 11.6%
Book Value: ₹56.7
Dividend Yield: 0.00%
52W High / Low: ₹210/92.0

In Jun 2026, AMANTA HEALTHCARE LIMITED (AMANTA) reported sales ₹68.80 Cr and net profit ₹3.31 Cr.

Annual TTM: sales ₹291 Cr, net profit ₹15 Cr.

Shareholding: Promoters 63.80% (Sep 2026), FIIs 0.07% (Sep 2026), DIIs 12.20% (Sep 2026), Public 23.93% (Sep 2026), No. of Shareholders 12,319% (Sep 2026).

AMANTA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	66.73	67.81	72.06	65.31	70.89	74.49	76.99	68.80
Expenses	52.85	52.75	53.10	50.41	56.24	59.13	62.03	54.26
Operating Profit	13.88	15.06	18.96	14.90	14.65	15.36	14.96	14.54
OPM %	20.80%	22.21%	26.31%	22.81%	20.67%	20.62%	19.43%	21.13%
Other Income	0.21	0.87	0.16	0.96	-2.56	0.68	1.66	0.64
Interest	6.32	5.90	6.28	6.29	5.15	5.06	4.25	6.00
Depreciation	4.60	4.51	4.69	4.64	4.66	4.67	4.75	4.69
Profit before tax	3.17	5.52	8.15	4.93	2.28	6.31	7.62	4.49
Tax %	28.71%	22.64%	26.87%	28.80%	46.93%	26.47%	27.43%	26.28%
Net Profit	2.26	4.28	5.96	3.51	1.21	4.63	5.53	3.31
EPS in Rs	0.78	1.48	2.07	1.22	0.31	1.19	1.42	0.85
Raw PDF	—	—	—	—	—	—	—	—

AMANTA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	184	171	225	259	280	275	288	291
Expenses	147	133	173	206	223	215	228	232
Operating Profit	37	38	52	53	58	60	60	60
OPM %	20%	22%	23%	20%	21%	22%	21%	20%
Other Income	2	1	76	4	1	1	1	0
Interest	38	40	49	35	34	28	21	20
Depreciation	16	17	17	18	20	18	19	19
Profit before tax	-15	-18	62	3	5	15	21	21
Tax %	25%	23%	11%	179%	32%	29%	30%	—
Net Profit	-19	-22	55	-2	4	10	15	15
EPS in Rs	-7.03	-8.14	20.54	-0.79	1.35	3.64	3.83	3.77
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	—

AMANTA balance sheet (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	27	27	27	27	27	29	39
Reserves	2	-20	36	36	39	68	181
Borrowings	231	235	226	216	211	204	244
Other Liabilities	127	150	104	96	75	81	93
Total Liabilities	388	392	392	374	352	382	558
Fixed Assets	244	242	240	232	228	217	207
CWIP	-0	-0	-0	9	-0	7	82
Investments	0	2	3	-0	4	8	7
Other Assets	144	149	149	133	120	150	262
Total Assets	388	392	392	374	352	382	558

AMANTA cash flows (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	38	31	62	43	58	47	48
Cash from Investing Activity	-9	-13	-6	-7	-10	-24	-94
Cash from Financing Activity	-37	-18	-50	-42	-46	-23	126
Net Cash Flow	-8	-0	6	-6	1	-1	81
Free Cash Flow	27	19	52	36	46	26	-32
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	102%	66%	119%	93%	111%	84%	93%

AMANTA shareholding pattern (%)
Category	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	63.56%	63.56%	63.72%	63.79%	63.80%
FIIs	1.00%	1.10%	0.85%	0.43%	0.07%
DIIs	11.34%	11.24%	12.88%	12.92%	12.20%
Public	24.10%	24.09%	22.55%	22.84%	23.93%
No. of Shareholders	18,669	16,181	15,222	12,612	12,319

AMANTA key ratios
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	104	110	73	75	63	67	55
Inventory Days	225	422	338	247	309	464	530
Days Payable	99	186	185	130	129	194	230
Cash Conversion Cycle	229	345	226	193	243	336	354
Working Capital Days	51	-5	28	42	16	26	6
ROCE %	—	9%	14%	13%	14%	15%	12%

AMANTAUpdated 17 Oct 2026, 21:32

Amanta Healthcare Limited

AMANTAUpdated 17 Oct 2026, 21:32

Market Cap

₹712Cr.

Current Price

₹183

High / Low

₹210/92.0

Stock P/E

46.4

ROE10.3%

ROCE11.6%

Book Value₹56.7

Face Value₹10.0

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2024	68.1	9.45	54.7	0.15	4.6	-0.5	-28	-0.36	-0.13
Sep 2024	66.73	6.32	52.85	0.21	4.6	3.17	28.71	2.26	0.78
Dec 2024	67.81	5.9	52.75	0.87	4.51	5.52	22.64	4.28	1.48
Mar 2025	72.06	6.28	53.1	0.16	4.69	8.15	26.87	5.96	2.07
Jun 2025	65.31	6.29	50.41	0.96	4.64	4.93	28.8	3.51	1.22
Sep 2025	70.89	5.15	56.24	-2.56	4.66	2.28	46.93	1.21	0.31
Dec 2025	74.49	5.06	59.13	0.68	4.67	6.31	26.47	4.63	1.19
Mar 2026	76.99	4.25	62.03	1.66	4.75	7.62	27.43	5.53	1.42
Jun 2026	68.8	6	54.26	0.64	4.69	4.49	26.28	3.31	0.85

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2020	184	38	147	2	16	-15	25	-19	-7.03
Mar 2021	171	40	133	1	17	-18	23	-22	-8.14
Mar 2022	225	49	173	76	17	62	11	55	20.54
Mar 2023	259	35	206	4	18	3	179	-2	-0.79
Mar 2024	280	34	223	1	20	5	32	4	1.35
Mar 2025	275	28	215	1	18	15	29	10	3.64
Mar 2026	288	21	228	1	19	21	30	15	3.83
TTM	291	20	232	0	19	21	—	15	3.77

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	63.8%
FIIs	0.07%
DIIs	12.2%
Public	23.93%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2025	63.56%	1%	11.34%	24.1%
Dec 2025	63.56%	1.1%	11.24%	24.09%
Mar 2026	63.72%	0.85%	12.88%	22.55%
Jun 2026	63.79%	0.43%	12.92%	22.84%
Sep 2026	63.8%	0.07%	12.2%	23.93%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2020	27	2	231	127	388	244	0	0	144	388
Mar 2021	27	-20	235	150	392	242	0	2	149	392
Mar 2022	27	36	226	104	392	240	0	3	149	392
Mar 2023	27	36	216	96	374	232	9	0	133	374
Mar 2024	27	39	211	75	352	228	0	4	120	352
Mar 2025	29	68	204	81	382	217	7	8	150	382
Mar 2026	39	181	244	93	558	207	82	7	262	558

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2020	38	-9	-37	-8
Mar 2021	31	-13	-18	0
Mar 2022	62	-6	-50	6
Mar 2023	43	-7	-42	-6
Mar 2024	58	-10	-46	1
Mar 2025	47	-24	-23	-1
Mar 2026	48	-94	126	81

Key ratios

Historical financial ratios

Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	104	110	73	75	63	67	55
Inventory Days	225	422	338	247	309	464	530
Days Payable	99	186	185	130	129	194	230
Cash Conversion Cycle	229	345	226	193	243	336	354
Working Capital Days	51	-5	28	42	16	26	6
ROCE %	—	9%	14%	13%	14%	15%	12%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of AMANTA HEALTHCARE LIMITED (AMANTA)?

The reported market capitalisation for AMANTA HEALTHCARE LIMITED (AMANTA) is ₹712Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of AMANTA?

The current price shown for AMANTA HEALTHCARE LIMITED (AMANTA) on Fincrux is ₹183 with a 52-week high/low of ₹210/92.0.

What is the P/E ratio of AMANTA HEALTHCARE LIMITED (AMANTA)?

The stock P/E for AMANTA HEALTHCARE LIMITED (AMANTA) is 46.4 on Fincrux, with ROE at 10.3% and ROCE at 11.6%.

What were AMANTA latest quarterly results?

For Jun 2026, AMANTA HEALTHCARE LIMITED (AMANTA) reported sales ₹68.80 Cr and net profit ₹3.31 Cr (figures in ₹ crore unless noted).

What are AMANTA annual sales and net profit?

For TTM, AMANTA HEALTHCARE LIMITED (AMANTA) shows sales of ₹291 Cr and net profit of ₹15 Cr on the Fincrux profit & loss statement.

Who owns AMANTA HEALTHCARE LIMITED (AMANTA)?

Latest shareholding for AMANTA HEALTHCARE LIMITED (AMANTA) on Fincrux: Promoters 63.80% (Sep 2026), FIIs 0.07% (Sep 2026), DIIs 12.20% (Sep 2026), Public 23.93% (Sep 2026), No. of Shareholders 12,319% (Sep 2026).

Where can I find AMANTA HEALTHCARE LIMITED (AMANTA) financials?

AMANTA HEALTHCARE LIMITED (AMANTA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show AMANTA balance sheet and cash flow?

Yes. The AMANTA HEALTHCARE LIMITED (AMANTA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 17 October 2026 at 21:32